Marketing-authorisation holder
Melinta Therap
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| KIMYRSA1.2gm base/vial · Powder | Oritavancin diphosphate | United States | Marketed | 2021 |
| ORBACTIV400mg base/vial · Powder | Oritavancin diphosphate | United States | Marketed | 2014 |
| TOPROL-XL100mg tartrate | 200mg tartrate | 25mg tartrate | 50mg tartrate · Tablet, extended release | Metoprolol | United States | Marketed | 1992 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 3 | 3 | 0 | CompaniesAll medicines |
Top substances
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 1
- Roles
- Authorisation holder
Work with Prognia
Keep Melinta Therap’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a call